Home / Health / India may not alter cornavirus treatment protocol to add drug hailed in UK

India may not alter cornavirus treatment protocol to add drug hailed in UK

Trial results in Britain showed dexamethasone reduced death rates by around a third among the most severely ill Covid-19 patients admitted to hospital

Premium

Scientists at the Oxford University said their randomised controlled trial showed the steroid reduces death by up to one-third among those hospitalised with severe respiratory complications of Covid-19.

Sohini Das Mumbai

2 min read Last Updated : Jun 18 2020 | 9:42 AM IST

India may not immediately alter its Covid-19 treatment protocol to include the steroid dexamethasone, given it already uses steroids on patients. Meanwhile, the Covid-19 task force in Mumbai has asked the government to make Gilead drug Remdesivir available at the earliest, as it could save many lives.

Dexamethasone, an inexpensive steroid available widely in India, is the latest drug touted to reduce the risk of death. The drug has been manufactured by Zydus Cadila and Wockhardt, with market size of Rs 100 crore — which is mostly stagnant.

A government source said: “The drug is easily available here. We can use it

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in